Rafee Talukder

Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events

Faisal Fa’ak, Maryam Buni, Adewunmi Falohun et al. · Journal for ImmunoTherapy of Cancer · 2023 · 95 citations · Full text

Pharmacy, Immunology, Oncology +17

Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study

Vadim S. Koshkin, Nicholas Henderson, Marihella James et al. · Cancer · 2021 · 85 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma

Dimitrios Makrakis, Rafee Talukder, Genevieve Ihsiu Lin et al. · Clinical Genitourinary Cancer · 2022 · 27 citations · Full text

Medicine, Oncology, Urology +16

Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): “Real World” Experience

Dimitra Rafailia Bakaloudi, Rafee Talukder, Genevieve Ihsiu Lin et al. · Clinical Genitourinary Cancer · 2023 · 27 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma

Dimitrios Makrakis, Dimitra Rafailia Bakaloudi, Rafee Talukder et al. · Clinical Genitourinary Cancer · 2022 · 23 citations · Full text

Medicine, Immunology, Oncology +16